An upregulation of CCN2/CTGF was observed in reactive astrocytes during other neurodegenerative diseases like multiple sclerosis (Holley et al., 2003), amyotrophic lateral sclerosis (Spliet et al., 2003) and Alzheimer’s disease (Ueberham et al., 2003). Here, CCN2 is linked to Alzheimer disease.